Researchers at the Brown School at Washington University in St. Louis are conducting discussion groups with parents and staff in the Special School District of St. Louis County (SSD) to develop communication tools surrounding COVID-19 testing and vaccination.
Employees with close patient contact begin receiving Pfizer vaccine; older ages prioritized
The Fall 2020 Skandalaris LEAP cycle has ended and a new set of translational research projects have been funded. LEAP is an asset development program and gap fund designed to provide intellectual and financial capital to WashU affiliate translational projects.
CCHPR shares highlights from 2020 in end of year newsletter. Read it here.
Researchers at Washington University School of Medicine in St. Louis have received a two-year, $5 million grant to offer 50,000 saliva tests for the SARS-CoV-2 virus to students, teachers and staff in the six special education schools operated by the Special School District of St. Louis County (SSD).
Findings indicate anti-inflammatory drugs likely to benefit only a fraction of people with severe disease
A look at how Washington University came together in the spring and summer to respond to the COVID-19 outbreak — and to prepare for a fall semester that is anything but back to normal.
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen […]
New findings from researchers at Washington University School of Medicine in St. Louis suggest the eye’s cornea can resist infection from the novel coronavirus. Although the herpes simplex virus can infect the cornea and spread to other parts of the body in patients with compromised immune systems, and Zika virus has been found in tears […]